FreedomDev builds digital ISO 13485:2016 quality management systems for medical device manufacturers — design controls, document control, CAPA, risk management integrated with ISO 14971, supplier management, management review, and Notified Body audit readiness. From startup device companies pursuing first CE marking to established manufacturers aligning legacy QMS infrastructure with EU MDR 2017/745 and FDA 21 CFR Part 820 requirements, we deliver validated QMS software that replaces paper-based quality systems with enforceable digital workflows.
ISO 13485:2016 is the internationally recognized quality management system standard for medical device manufacturers. It is not optional. If you sell devices in the European Union, your Notified Body requires a certified ISO 13485 QMS as a prerequisite for CE marking under the EU Medical Devices Regulation (MDR 2017/745). If you sell in the United States, FDA's Quality System Regulation (21 CFR Part 820) shares roughly 80% of its requirements with ISO 13485 — and the FDA has publicly announced its intention to harmonize Part 820 with ISO 13485 through the proposed QMSR (Quality Management System Regulation) rule. If you sell in Canada, Health Canada requires ISO 13485 certification through the MDSAP (Medical Device Single Audit Program). Japan, Australia, and Brazil operate under the same MDSAP framework. ISO 13485 certification is not a quality badge you hang on the wall. It is the regulatory foundation that determines whether you can legally sell medical devices in every major market on Earth.
Most medical device companies under 500 employees run their ISO 13485 QMS on a combination of paper forms, Word documents, Excel spreadsheets, shared drives, and email approval chains. Design history files live in folder structures on a file server. CAPA records exist in spreadsheets with manual status tracking. Document control runs on a Word template with revision tables that someone manually updates. Management review data is compiled by hand from six different sources over two weeks before the meeting. Training records are signed paper forms scanned into PDFs and stored in a folder that nobody can efficiently search. This works — barely — at 20 employees with 3 products. It collapses at 75 employees with 12 products across multiple sites. The typical failure mode is not dramatic. It is a slow accumulation of uncontrolled documents, overdue CAPAs, training gaps that nobody notices, and supplier evaluations that slip past their due dates. Then the Notified Body auditor arrives, pulls one thread, and the entire system unravels in a single audit finding.
The cost of ISO 13485 nonconformities during a Notified Body audit is measured in market access delays. A major nonconformity — defined as a failure that affects the ability of the QMS to achieve its intended results or a complete absence of a required QMS process — requires a formal corrective action plan submitted within a defined timeframe, typically 30 to 90 days. The Notified Body will not issue or renew your ISO 13485 certificate until every major nonconformity is closed with objective evidence of correction. If your certificate lapses, your CE marking is invalid, and you cannot legally place devices on the EU market. For a device company generating $5M-$50M in EU revenue, a six-month certificate suspension is not an inconvenience. It is a revenue event that triggers downstream consequences: hospital contract penalties, distributor relationship damage, and competitor entrenchment that persists long after your certificate is restored. The 2024 MDR implementation transition exposed this at scale — dozens of device companies lost EU market access because their QMS infrastructure could not demonstrate conformity with the more stringent MDR requirements that Notified Bodies now enforce during ISO 13485 audits.
Notified Body major nonconformities trigger 30-90 day corrective action deadlines that delay or suspend ISO 13485 certification and halt EU market access
Paper-based CAPA systems average 45-90 day closure times versus 15-30 days in digital systems — overdue CAPAs are the #1 audit finding across medical device companies
Design history files scattered across shared drives, email attachments, and local machines cannot demonstrate the traceability that ISO 13485 clause 7.3.2 requires
Document control failures (superseded documents in circulation, missing approval signatures, uncontrolled copies) account for 30%+ of ISO 13485 audit nonconformities
Supplier evaluation records maintained in spreadsheets miss re-evaluation due dates and cannot link supplier performance to incoming inspection data or complaint trends
Management review preparation requires 2-3 weeks of manual data compilation from disconnected systems — quality metrics arrive stale and incomplete
Our engineers have built this exact solution for other businesses. Let's discuss your requirements.
FreedomDev builds ISO 13485:2016 quality management systems where every clause requirement is encoded as a digital workflow rather than a paper procedure that depends on human memory and discipline. Clause 4.2.4 (Control of Documents) becomes an enforced document lifecycle with mandatory review, electronic approval signatures, automatic version control, and controlled distribution that physically prevents access to superseded documents. Clause 7.3 (Design and Development) becomes a gated design control process where design inputs must be formally reviewed and approved before design outputs can be recorded, where design verification evidence is linked to specific design outputs, and where design validation cannot be closed without traceable evidence addressing every design input requirement. Clause 8.2.3 (Monitoring and Measurement of Processes) becomes real-time quality dashboards that surface CAPA aging, complaint trends, nonconformance rates, and audit schedule status — the data your management representative currently spends two weeks compiling into PowerPoint slides before each management review meeting.
The system architecture maps directly to the ISO 13485:2016 clause structure. Section 4 (Quality Management System) is implemented as the document control module, quality manual management, and QMS process interaction mapping. Section 5 (Management Responsibility) is implemented as management review scheduling, quality objective tracking, resource allocation dashboards, and quality policy acknowledgment workflows. Section 6 (Resource Management) covers training management, competence records, infrastructure maintenance tracking, and work environment monitoring for controlled production areas. Section 7 (Product Realization) is the largest module: design controls, purchasing and supplier management, production controls, monitoring and measurement, and traceability. Section 8 (Measurement, Analysis, and Improvement) covers internal audits, CAPA management, nonconformance handling, complaint processing, and data analysis for continuous improvement. Every module connects to every other module because ISO 13485 requirements are interdependent — a customer complaint (8.2.1) may trigger a CAPA (8.5.2) that results in a design change (7.3.7) that requires supplier requalification (7.4.1) and updated production documentation (7.5.1). Paper systems cannot maintain these linkages. Digital systems enforce them.
The critical difference between FreedomDev's approach and off-the-shelf eQMS platforms like Greenlight Guru, MasterControl, Qualio, or Arena is implementation depth and regulatory specificity. Off-the-shelf platforms provide configurable frameworks — blank forms, generic workflow engines, and template libraries that you must configure to match your specific QMS processes. Configuration takes 3-6 months, costs $50,000-$150,000 in implementation consulting fees on top of licensing, and still requires your quality team to define every workflow, approval chain, and data relationship. When the Notified Body asks why your CAPA process works the way it does, the answer cannot be 'because that is how the software was configured.' The answer must trace to your quality manual, your SOPs, and your regulatory requirements. FreedomDev builds the QMS software from your quality manual outward — your procedures become the system's logic, your regulatory requirements become the system's constraints, and your quality objectives become the system's metrics. The result is a QMS that your quality team recognizes as their system implemented in software rather than a generic platform they have been forced to adapt to.
Full design control workflow from design planning through design transfer, mapped to both ISO 13485 clause 7.3 subclauses and FDA 21 CFR 820.30. Design inputs are formally captured with acceptance criteria, categorized by source (customer requirements, regulatory requirements, applicable standards, risk analysis outputs), and reviewed for adequacy, completeness, and absence of ambiguity or conflict per clause 7.3.3. Design outputs are documented in terms that allow verification against design inputs per clause 7.3.4 — the system enforces the linkage and flags unaddressed inputs. Design reviews are scheduled per the design plan with mandatory independent reviewer participation and documented action item tracking to closure. Design verification links specific test evidence to specific design outputs. Design validation links clinical or simulated-use evidence to user needs and intended use. Design transfer captures the manufacturing specifications, acceptance criteria, and production procedures that enable consistent production. The design history file is generated automatically from these linked records — not assembled after the fact by a regulatory affairs specialist pulling documents from six different folders.
Every controlled document follows an enforced lifecycle: draft, review, approval, effective, and obsolete. Authors create documents within the system. Reviewers and approvers are assigned based on document type and affected functional areas — the system will not allow a document to become effective without all required approval signatures. Electronic signatures comply with 21 CFR Part 11 requirements: dual-component authentication, signature manifestation (printed name, date, time, meaning), and tamper-proof binding to the signed document. When a new document version is approved, the previous version automatically transitions to obsolete status and is removed from active circulation. Personnel who need the document receive notification of the new version and, if training is required, cannot access the document for operational use until training acknowledgment is recorded. External documents from customers, suppliers, and regulatory bodies are registered in the system with review dates, responsible owners, and change notification tracking. The system maintains the master list of controlled documents required by clause 4.2.4 automatically — no manual spreadsheet required.
Corrective and Preventive Action workflows enforce investigation rigor and timeline compliance. CAPAs are initiated from multiple sources: customer complaints, internal audit findings, nonconformance trends, process monitoring data, management review action items, and Notified Body audit observations. Each CAPA record captures the problem description, immediate containment actions, root cause investigation (supporting 8D, 5-Why, Fishbone, and Fault Tree methodologies), planned corrective or preventive actions, responsible persons, target completion dates, and effectiveness verification criteria. The system enforces escalation rules: CAPAs approaching their target date trigger automated notifications, overdue CAPAs escalate to quality management, and CAPAs that exceed defined aging thresholds (configurable per severity level) generate management alerts. Effectiveness verification is scheduled automatically — typically 30, 60, and 90 days post-implementation — and the CAPA cannot be closed until effectiveness evidence demonstrates that the root cause has been eliminated and the problem has not recurred. CAPA trending reports surface systemic patterns: recurring root causes, product lines with elevated CAPA rates, and process areas generating repeated nonconformances.
ISO 13485 clause 7.1 requires risk management throughout product realization, and ISO 14971:2019 defines the process. Our QMS integrates risk management as a cross-cutting function rather than a standalone module. The risk management file is a living collection of linked records: intended use and reasonably foreseeable misuse documentation, hazard identification worksheets, risk estimation records (severity and probability of occurrence for each hazardous situation), risk evaluation against your defined acceptability criteria, risk control measures traced to specific design decisions or production controls, residual risk evaluation after controls are implemented, and risk-benefit analysis where residual risk exceeds acceptability criteria. Risk controls are linked bidirectionally to design outputs (for design-phase controls) and production procedures (for production-phase controls). When a design change is proposed, the system automatically identifies affected risk control measures and requires re-evaluation before the change can be approved. Post-production information — complaints, CAPA data, literature monitoring — feeds back into the risk management file through automated linkages, satisfying clause 10.3 of ISO 14971:2019 (production and post-production information).
Clause 7.4.1 requires that purchased product conforming to purchasing requirements is ensured through controls proportional to the effect on subsequent product realization or the final medical device. The supplier management module captures the full supplier lifecycle: initial qualification assessment (including quality system evaluation, regulatory status verification, and capability assessment), approved supplier list maintenance, purchasing controls with requirement specification, incoming inspection management, supplier performance monitoring (on-time delivery, rejection rates, nonconformance frequency, CAPA responsiveness), and periodic re-evaluation on a defined schedule. Supplier risk classification drives the depth of qualification and monitoring activities — a contract manufacturer producing a critical component requires more extensive initial qualification and more frequent re-evaluation than a supplier of office consumables. When incoming inspection reveals a nonconformance, the system initiates the supplier nonconformance workflow: notification to the supplier, disposition of affected material (accept, reject, return, rework), root cause request to the supplier with tracking to closure, and automatic recalculation of the supplier's quality score. Re-evaluation schedules are tracked with automated reminders and escalation — no more spreadsheet-based supplier review calendars with missed due dates.
Clause 5.6.2 defines the required inputs for management review: audit results, customer feedback, process performance and product conformity, status of preventive and corrective actions, follow-up actions from previous management reviews, changes that could affect the QMS, and recommendations for improvement. In a paper-based QMS, assembling this data takes two to three weeks of manual compilation from disconnected sources. In FreedomDev's digital QMS, management review input data is generated automatically from operational records already in the system. Audit findings and their closure status pull from the internal audit module. Customer feedback aggregates from the complaint management system. Process performance metrics pull from quality objective dashboards. CAPA status reports generate from the CAPA module with aging analysis and trending. Regulatory change impact assessments pull from the regulatory intelligence function. The management review meeting agenda and input package generate on demand or on schedule, and the meeting output — decisions, action items, resource allocation changes, improvement initiatives — is recorded directly in the system with assigned owners, target dates, and tracking to closure. The next management review automatically includes follow-up status on all previous action items.
The internal audit program requires audit scheduling based on process importance and previous audit results per clause 8.2.2. Our system manages the complete audit lifecycle: annual audit program planning with risk-based scheduling (processes with previous nonconformities or regulatory significance receive more frequent audits), audit assignment with auditor independence verification (the system will not assign an auditor to evaluate their own functional area), audit checklist generation mapped to specific ISO 13485 clauses and your SOP requirements, finding documentation with classification (major nonconformity, minor nonconformity, observation, opportunity for improvement), corrective action assignment and tracking linked to the CAPA module, and audit closure with effectiveness verification. Audit reports generate automatically from finding records with traceable objective evidence. The audit program dashboard shows scheduled versus completed audits, open findings by severity, overdue corrective actions, and trend analysis across audit cycles — exactly the data your Notified Body auditor requests when evaluating the effectiveness of your internal audit program.
The EU Medical Devices Regulation imposes requirements beyond what ISO 13485 alone covers. Article 83 requires a post-market surveillance system proportionate to the risk class of the device. Article 85 requires a Post-Market Surveillance Report for Class I devices and a Periodic Safety Update Report (PSUR) for Class IIa, IIb, and III devices — the PSUR must be updated annually for Class IIa and Class IIb devices and at least every six months for Class III devices during the first two years after CE marking. Article 87 requires reporting of serious incidents through the EUDAMED vigilance module. Annex IX (Quality Management System Assessment) defines the Notified Body's audit scope for QMS certification and requires that your QMS cover every aspect of the MDR that applies to your device classification. FreedomDev's QMS includes MDR-specific modules: post-market surveillance plan management, complaint trending analysis with MDR serious incident classification, PSUR generation with the data elements specified in MDR Annex III Section 1.1(b), clinical evaluation report linkage to post-market clinical follow-up data, and Unique Device Identification (UDI) management per Article 27. These modules integrate with your ISO 13485 QMS core so that compliance data flows from one standard's requirement to the other without duplicate entry.
We had been running ISO 13485 on paper and shared drives for eight years. Our last Notified Body audit produced four major nonconformities, all related to document control and CAPA traceability. FreedomDev digitized our entire QMS in five months. Our next surveillance audit closed with zero major findings and two minor observations — both unrelated to the system. The auditor specifically noted the quality of our design history file traceability as a strength.
We conduct a detailed gap assessment of your current quality management system against every applicable clause of ISO 13485:2016 and, where applicable, FDA 21 CFR Part 820, EU MDR 2017/745 Annex IX, and MDSAP requirements. For each clause, we document the current state (how you comply today), the gap (what is missing, incomplete, or dependent on manual processes), and the target state (how the digital QMS will address the requirement). We review your existing quality manual, SOPs, work instructions, forms, and records to identify what carries over into the digital system and what needs to be rewritten. For companies pursuing first ISO 13485 certification, we develop the QMS documentation framework in parallel with the system design. Deliverable: a clause-by-clause compliance matrix with system requirements specifications for every QMS process that will be digitized.
We design the digital QMS architecture based on the clause mapping from Step 1. Every QMS process — document control, design controls, CAPA, supplier management, complaint handling, internal audit, management review, training, production controls — is modeled as a state machine with defined entry conditions, transition rules, authorization requirements, evidence capture points, and exit criteria. Approval chains map to your organizational structure and quality procedures. Notification and escalation rules reflect your SOP-defined timelines. Data relationships between modules mirror the interdependencies in your quality system — a complaint links to a CAPA, which links to a design change, which links to a risk management update, which triggers supplier re-evaluation. For FDA-regulated companies requiring 21 CFR Part 11 compliance, we design the audit trail architecture, electronic signature implementation, and validation strategy (GAMP 5 methodology) in this phase. Your quality team reviews and approves every workflow design before development begins.
We build the QMS in module sequence prioritized by audit risk and operational impact. Document control and audit trail functionality are always built first because they underpin every other module — once document control is live, your team immediately begins working with controlled electronic documents instead of paper. Design controls and CAPA modules follow because these are the highest-scrutiny areas during Notified Body audits. Supplier management, complaint handling, internal audit, management review, and training management are built in the subsequent phases. Each module is developed with full traceability from the clause mapping requirements through design specifications to test evidence. Integration with your existing systems — ERP for purchasing data, production systems for manufacturing records, document storage for legacy file migration — happens incrementally. We migrate your existing QMS records (open CAPAs, active design files, current supplier approvals, training records) into the new system so that you do not lose continuity or audit history.
For FDA-regulated environments, we execute the full IQ/OQ/PQ validation protocol per GAMP 5 Category 5 guidelines. Installation Qualification verifies that all system components are installed per specifications. Operational Qualification tests every function against its requirements specification under normal, boundary, and error conditions. Performance Qualification demonstrates sustained reliable operation with your production data, your users, and your actual quality workflows. Validation deliverables include the validation plan, requirements traceability matrix, test protocols, executed test records, deviation reports, and the validation summary report. For Notified Body audit readiness, we prepare the QMS technical file: system architecture documentation, data integrity controls, backup and recovery procedures, access control specifications, and change management procedures for the QMS software itself. We also conduct a mock audit of the digital QMS against your Notified Body's typical audit checklist to identify any remaining gaps before the certification audit.
We deploy in phases aligned with your certification timeline. Phase 1 (document control and training management) goes live first to establish the controlled document environment. Phase 2 (CAPA, complaint handling, and nonconformance management) activates the quality event workflows. Phase 3 (design controls, supplier management, internal audit, and management review) completes the QMS digitization. Each phase includes role-specific training: quality engineers learn CAPA investigation and root cause analysis workflows, document control specialists learn review and approval administration, design engineers learn the design control process, procurement learns supplier qualification and monitoring, and management learns the review dashboard and quality objective tracking. Post-deployment support includes regulatory change monitoring (ISO 13485 amendments, FDA QMSR updates, EU MDR implementing guidance), system updates, Notified Body audit support, and ongoing optimization based on user feedback and quality data analysis. Maintenance runs $2,500-$6,000/month depending on system scope and regulatory complexity.
| Metric | With FreedomDev | Without |
|---|---|---|
| ISO 13485 Clause Coverage | Every clause mapped to enforced digital workflow with built-in interdependencies | Configurable templates that your team must map to clauses manually |
| Implementation Time | 4-6 months (clause-mapped architecture, validated, audit-ready) | 6-12 months (platform licensing + configuration + validation + SOP adaptation) |
| Implementation Cost | $120K-$300K (complete validated QMS) | Greenlight Guru / MasterControl: $80K-$200K+ licensing + $50K-$150K implementation consulting |
| Annual Cost (Year 2+) | $30K-$72K maintenance (includes regulatory change monitoring) | $60K-$200K+ annual licensing (per-user pricing scales with headcount) |
| FDA 21 CFR Part 820 Alignment | Dual-mapped to both ISO 13485 and 21 CFR Part 820 clause-by-clause from architecture phase | ISO 13485 framework with Part 820 mapping as an add-on configuration |
| EU MDR Compliance Modules | PMS plans, PSUR generation, vigilance reporting, UDI management integrated natively | MDR features added via updates; PSUR generation often requires manual compilation |
| Risk Management (ISO 14971) | Risk file integrated with design controls, CAPA, and post-market data bidirectionally | Standalone risk module that requires manual linkage to other QMS processes |
| Notified Body Audit Support | Mock audit included; system generates audit evidence packages on demand | Audit preparation is customer responsibility; platform provides export tools |
Schedule a direct technical consultation with our senior architects.
Make your software work for you. Let's build a sensible solution.